CureVac (DE:5CV)
XETRA:5CV
Holding DE:5CV?
Track your performance easily

CureVac (5CV) Financial Statements

8 Followers

CureVac Financial Overview

CureVac's market cap is currently ―. The company's EPS TTM is €-1.242; its P/E ratio is -2.14; CureVac is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is €1.41. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 11.21M$ 20.15M$ 24.37M
Gross Profit--$ -12.87M$ -22.54M$ -12.86M
EBIT--$ -47.10M$ -56.98M$ -13.25M
EBITDA--$ -40.41M$ -49.40M$ -4.17M
Net Income Common Stockholders--$ -47.57M$ -57.58M$ -15.09M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 402.45M$ 495.80M$ 543.46M$ 577.17M$ 662.87M
Total Assets$ 788.25M$ 860.47M$ 910.51M$ 925.82M$ 1.03B
Total Debt$ 41.82M$ 42.09M$ 41.26M$ 40.21M$ 40.66M
Net Debt$ -360.63M$ -453.71M$ -502.20M$ -536.97M$ -622.21M
Total Liabilities$ 271.31M$ 327.22M$ 285.52M$ 302.62M$ 351.80M
Stockholders Equity$ 516.94M$ 509.85M$ 624.99M$ 623.20M$ 674.86M
Cash Flow-
Free Cash Flow--$ -63.76M$ -92.19M$ -153.70M
Operating Cash Flow--$ -35.92M$ -64.66M$ -136.51M
Investing Cash Flow--$ -27.84M$ -27.53M$ -17.18M
Financing Cash Flow--$ 26.46M$ 3.87M$ -460.00K
Currency in USD

CureVac Earnings and Revenue History

CureVac Debt to Assets

CureVac Cash Flow

CureVac Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis